Procardia (nifedipine) belongs to which drug class and is contraindicated in which condition?

Prepare for the NCC Credential in Inpatient Antepartum Nursing. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

Procardia (nifedipine) belongs to which drug class and is contraindicated in which condition?

Explanation:
Nifedipine is a calcium channel blocker, specifically a dihydropyridine. It works by blocking L-type calcium channels in vascular smooth muscle, causing arterial dilation, lowering systemic vascular resistance, and reducing afterload. Because of this BP-lowering effect, it can decrease cardiac workload and perfusion. In patients with cardiac disease, especially when cardiac reserve is limited, this drop in blood pressure and potential reduction in coronary perfusion can worsen symptoms or compromise cardiac output. That’s why this drug is considered contraindicated in cardiac disease. The other pairings don’t match nifedipine’s pharmacology: a beta blocker acts on beta-adrenergic receptors, a prostaglandin inhibitor affects inflammatory pathways, and an alpha agonist tends to raise blood pressure.

Nifedipine is a calcium channel blocker, specifically a dihydropyridine. It works by blocking L-type calcium channels in vascular smooth muscle, causing arterial dilation, lowering systemic vascular resistance, and reducing afterload. Because of this BP-lowering effect, it can decrease cardiac workload and perfusion. In patients with cardiac disease, especially when cardiac reserve is limited, this drop in blood pressure and potential reduction in coronary perfusion can worsen symptoms or compromise cardiac output. That’s why this drug is considered contraindicated in cardiac disease.

The other pairings don’t match nifedipine’s pharmacology: a beta blocker acts on beta-adrenergic receptors, a prostaglandin inhibitor affects inflammatory pathways, and an alpha agonist tends to raise blood pressure.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy